The Clinical Biospecimen and Research Core
The Clinical Biospecimen and Research Core
批准号:
10612956
负责人:
Julian Abrams
金额:
$22.75万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-30 至 2027-03-31
关键词:
AgreementAreaBasic ScienceBioinformaticsBiometryCancer CenterCell Culture TechniquesCell NucleusCellsClinicalClinical DataClinical InvestigatorClinical ResearchClinical effectivenessCollaborationsCollectionConsultationsDataData ElementDatabasesDigestive System DisordersDiseaseEducationEducational workshopElectronic Health RecordEnsureEpithelial CellsFeedbackFertilizationFreezingFundingGoalsHomeostasisHumanHuman Subject ResearchImageImmunologic MonitoringInfrastructureInstitutionInterdisciplinary StudyLeadershipLinkLiver diseasesLongevityMissionModelingOrganOrganizational EfficiencyOrganoidsPatient SelectionPatientsQualifyingQuality ControlRNARecordsResearchResearch DesignResearch PersonnelResearch SupportResearch TrainingResourcesSamplingScienceScientistServicesSpecimenStructureSurveysTissue MicroarrayTissuesTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkbiobankbioimagingcost effectivedata integrationdata managementempowermenthistopathological examinationhuman subjectinnovationinterestmeetingsmembernext generationnoveloperationpatient populationpreventprogramsrepositorysingle cell analysissingle nucleus RNA-sequencingsymposiumtranslational study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overall goal of the Clinical Biospecimen and Research Core (CBRC) is to facilitate the conduct of clinical
and translational studies in the Columbia University Digestive and Liver Disease Research Center (CU-DLDRC).
The CBRC will provide research navigation services to its members to access extensive collections and storage
of digestive organ biospecimens. This resource will also combine biospecimen collection and analysis with
comprehensive clinical data elements. In concert with other CU-DLDRC Biomedical Cores, CBRC will enable
state-of-the-art single cell, imaging and organoid modelling-based analyses of its biospecimens through multi-
core workflows, thereby linking to the central theme “Epithelial Cells and Their Interactions in Digestive
Homeostasis and Disease” in human relevant settings. Through collaborative agreements with established
structures in the Cancer Center and Human Immune Monitoring cores, we will offer subsidized services such as
single nucleus RNA-sequencing, tissue microarrays, expert histopathological examination and biostatistical
support, thereby enhancing the capability of the CU-DLDRC to conduct impactful translational research.
Collaborative translational research and cross-fertilization between clinical and basic investigators in the CU-
DLDRC will be fertilized through a central infrastructure and consultative services for clinical research design
and application under the umbrella of organ-specific clinical-basic teams. The organ-specific clinical-basic teams
will support the analysis of CBRC-provided biospecimens in the CU-DLDRC biomedical cores through combined
clinical and basic expertise and dialogue, and vice versa, will bring novel basic research concepts from bench to
beside. The CBRC will led by two highly qualified NIH-funded clinical investigators, Dr. Julian Abrams (Director)
and Dr. Elizabeth Verna (Associate Director). The following Specific Aims will maximize benefits and added value
to CU-DLDRC members and contribute to the mission of the CU-DLDRC: To provide comprehensive biobanking
of digestive organ biospecimens with linked clinical data (Aim 1); to enable state-of-the-art translational analyses
of clinical samples (Aim 2); and to provide tailored human subjects research training, education, and biostatistical
support (Aim 3). According to user surveys, 96% of CU-DLDRC researchers plan to utilize CBRC services. In
conclusion, the CBRC will provide a crucial interface between clinical and basic CU-DLDRC investigators that
does not exist in this form at Columbia and promote high quality collaborative translational research through
access to a wealth of biospecimens. Through these services, the CBRC will provide major benefits to basic and
clinical CU-DLDRC researchers alike.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
-
批准号:10693227
-
项目类别:
-
资助金额:$81.24万
-
财政年份:2022
-
负责人:Julian Abrams
-
依托单位:
The Clinical Biospecimen and Research Core
-
批准号:10443135
-
项目类别:
-
资助金额:$23.82万
-
财政年份:2022
-
负责人:Julian Abrams
-
依托单位:
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia
-
批准号:10506039
-
项目类别:
-
资助金额:$84.51万
-
财政年份:2022
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microenvironment in Barrett's Esophagus
-
批准号:10607819
-
项目类别:
-
资助金额:$44.2万
-
财政年份:2022
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
-
批准号:10322389
-
项目类别:
-
资助金额:$51.08万
-
财政年份:2021
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
-
批准号:10747759
-
项目类别:
-
资助金额:$7.08万
-
财政年份:2021
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
-
批准号:10524194
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2021
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma
-
批准号:10543870
-
项目类别:
-
资助金额:$52.39万
-
财政年份:2021
-
负责人:Julian Abrams
-
依托单位:
The Role of the Metaplastic Microenvironment in Barrett's Esophagus
-
批准号:10381174
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2021
-
负责人:Julian Abrams
-
依托单位:
The Oral Microbiome for the Detection of Barretts Esophagus
-
批准号:10647639
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2019
-
负责人:Julian Abrams
-
依托单位:
Study of the Oral Microbiome to Address Racial Disparities in Esophageal Cancer
-
批准号:10249451
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2019
-
负责人:Julian Abrams
-
依托单位:
The Oral Microbiome for the Detection of Barretts Esophagus
-
批准号:10397032
-
项目类别:
-
资助金额:$54.51万
-
财政年份:2019
-
负责人:Julian Abrams
-
依托单位:
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus
-
批准号:8881844
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2015
-
负责人:Julian Abrams
-
依托单位:
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus
-
批准号:9050646
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2015
-
负责人:Julian Abrams
-
依托单位:
Administrative Core
-
批准号:10183176
-
项目类别:
-
资助金额:$5.93万
-
财政年份:2011
-
负责人:Julian Abrams
-
依托单位:
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus
-
批准号:10183180
-
项目类别:
-
资助金额:$47.48万
-
财政年份:2011
-
负责人:Julian Abrams
-
依托单位:
The Role of the Microenvironment in Barrett's Esophagus
-
批准号:10183175
-
项目类别:
-
资助金额:$114.54万
-
财政年份:2011
-
负责人:Julian Abrams
-
依托单位:
Risk factors for site-specific metastasis in esophageal cancer
-
批准号:7921303
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2009
-
负责人:Julian Abrams
-
依托单位:
Risk factors for site-specific metastasis in esophageal cancer
-
批准号:8308291
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2008
-
负责人:Julian Abrams
-
依托单位:
Risk factors for site-specific metastasis in esophageal cancer
-
批准号:7694297
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2008
-
负责人:Julian Abrams
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: